Seoulin Bioscience Co

Seoulin Bioscience Co EBIT per Employee

EBIT per Employee of Seoulin Bioscience Co (038070.KQ) as of Nov 4, 2026.

EBIT per Employee

-KRW

Last updated:

EBIT per Employee of Seoulin Bioscience Co is 2026 - KRW. EBIT per Employee of Seoulin Bioscience Co was 2025 - KRW. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seoulin Bioscience Co Stock analysis

What does Seoulin Bioscience Co do? SeouLin Bioscience Co., Ltd. generates revenue through the development and supply of reagents, including DNA chips for gene therapy, clinical diagnosis, organ transplantation, and biopsy, as well as stem cells for treating incurable diseases and Alzheimer's disease. The company markets these products under its brand MyLab and imports bio research equipment from Thermo Fisher, Affymetrix, and Sarstedt for domestic sales. Additionally, SeouLin Bioscience operates a real estate rental business to diversify its income streams. The primary customers for MyLab reagents and stem cell therapies are healthcare providers, research institutions, and medical facilities requiring advanced diagnostic and therapeutic solutions. Domestic market distribution of imported bio research equipment from Thermo Fisher, Affymetrix, and Sarstedt targets laboratories and hospitals seeking high-quality research tools. The real estate rental business serves commercial tenants in Seongnam, Gyeonggi-Do, where the company is headquartered. SeouLin Bioscience focuses on the lifescience sector, specifically targeting applications in gene therapy, clinical diagnostics, and regenerative medicine. Its product segments include DNA chips, stem cells, and next-generation biotechnology drugs, all under the MyLab brand. The company leverages strategic imports of bio research equipment to meet domestic demand for specialized laboratory tools. Seoulin Bioscience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Seoulin Bioscience Co stock

On Eulerpool you can find the complete historical development of EBIT per Employee Seoulin Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Seoulin Bioscience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Seoulin Bioscience Co

All Key Metrics — Seoulin Bioscience Co